date,title,source
Oct-22-18,Is a Beat in Store for Vertex (VRTX) This Earnings Season?,Zacks
Oct-24-18,Vertex Pharmaceuticals Inc (VRTX) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-26-18,3 Stocks to Buy and Hold for the Next 50 Years,Motley Fool
Oct-29-18,Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q2,Zacks
Oct-30-18,Is a Beat in Store for CRISPR (CRSP) This Earnings Season?,Zacks
Oct-31-18,Is a Beat in Store for Editas (EDIT) This Earnings Season?,Zacks
Nov-01-18,"Ophthotech (OPHT) Q3 Earnings Beat, Gene Therapy in Focus",Zacks
Nov-05-18,Here's Why CRISPR Stocks Fell as Much as 40.7% in October,Motley Fool
Nov-05-18,"ImmunoGen (IMGN) Beats on Earnings in Q3, Lowers Guidance",Zacks
Nov-05-18,5 Drug/Biotech Stocks Set to Trump Estimates in Q3 Earnings,Zacks
Nov-07-18,Cambridge's Editas asks FDA to start gene editing trial,American City Business Journals
Nov-07-18,CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-09-18,CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology,GlobeNewswire
Nov-12-18,CRISPR Therapeutics AG (CRSP) Stock Moves -0.55%: What You Should Know,Zacks
Nov-12-18,3 DNA Stocks That Are on the Uptrend,InvestorPlace
Nov-13-18,"New Research Coverage Highlights CAS Medical, Saia, Core Laboratories N.V, Perceptron, CRISPR Therapeutics AG, and IEC Electronics  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-21-18,CRISPR Therapeutics to Participate in Upcoming Investor Conferences,GlobeNewswire
Nov-26-18,"With genetically edited babies, a scientist transgresses a moral boundary",MarketWatch
Nov-26-18,Mass. biotech leaders voice alarm over report of first gene-edited babies,American City Business Journals
Nov-30-18,CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know,Zacks
Nov-30-18,This Biotech Stock Could Launch Its First CRISPR Drug In 2022,Investor's Business Daily
Nov-30-18,Why Crispr Therapeutics Stock Is Up By 65% So Far in 2018,Motley Fool
Dec-10-18,Here's Why Crispr Therapeutics Rose 17% in November,Motley Fool
Dec-10-18,Here's Why Editas Medicine Jumped 23% in November,Motley Fool
Dec-13-18,3 High-Growth Stocks That Are Just Getting Started,Motley Fool
Dec-13-18,Top 10 Healthcare Stories of 2018,Motley Fool
Dec-18-18,Gene-Editing Stocks Took Stutter Steps Forward in 2018,Motley Fool
Dec-18-18,Under Armour Tanks on Guidance,Motley Fool
Dec-19-18,Vertex's (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint,Zacks
Dec-19-18,Waltham's Eloxx aims to reach cystic fibrosis patients that Vertex can't,American City Business Journals
Dec-21-18,Did Chinas Designer Babies Just Open Pandoras Box?,Motley Fool
Dec-24-18,Don't Miss Chinese Biotechs,Motley Fool
Dec-27-18,3 Gene Therapy Stocks to Play Biotechs Future,InvestorPlace
Dec-27-18,Christmas Comes a Day Late,Zacks
Dec-31-18,Dow Rises 91 Points Because Everybodys Ready for a New Year,Barrons.com
Jan-03-19,Vertex teams up with Feng Zhang startup on gene editing tech,American City Business Journals
Jan-04-19,What Happened in the Stock Market Today,Motley Fool
Jan-04-19,These Stocks Pop After FDA Expedites Review Of Gene-Editing Therapy,Investor's Business Daily
Jan-04-19,CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease,GlobeNewswire
Jan-07-19,"Vertex, CRISPR's Sickle Disease Drug Gets FDA's Fast Track Tag",Zacks
Jan-07-19,Here's Why CRISPR Therapeutics Tanked 25.5% in December,Motley Fool
Jan-09-19,CRISPR cadre: Check out the 12 Mass. companies exploring gene editing,American City Business Journals
Jan-09-19,Market's Newfound Optimism Brings Another 1% Gain,Zacks
Jan-10-19,"The Best CRISPR Stock Gained 21% in 2018, While The Worst Lost 29%",Motley Fool
Jan-10-19,4 Reasons Editas Medicine's Future Looks Really Bright,Motley Fool
Jan-11-19,Why This IBD Stock Of The Day Broke Out Despite Biotech Turbulence,Investor's Business Daily
Jan-18-19,4 Gene-Editing Technologies That Could Replace CRISPR,Motley Fool
Jan-22-19,Should You Sell CRISPR Therapeutics Following an Analyst Downgrade?,Motley Fool
Jan-22-19,Here's Why CRISPR Therapeutics Stock Fell Today,Motley Fool
Jan-22-19,CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies,GlobeNewswire
Jan-23-19,Better Buy: CRISPR Therapeutics vs. Editas Medicine,Motley Fool
Jan-24-19,Vertex Terminates COO Ian Smith on Code of Conduct Violation,Zacks
Jan-28-19,CRISPR Stocks Flattened After 1 Downgraded Amid Steep Rivalry,Investor's Business Daily
Jan-28-19,Goldman Sachs Steps To The Sidelines On Crispr Therapeutics,Benzinga
Jan-30-19,Is a Beat in Store for Vertex (VRTX) This Earnings Season?,Zacks
Feb-01-19,3 Biotech Stocks That Are Set for a Breakthrough,InvestorPlace
Feb-05-19,Why Even a Pessimistic Analyst Thinks CRISPR Therapeutics Will Jump 20%,Motley Fool
Feb-06-19,Vertex (VRTX) Q4 Earnings Beat on Solid CF Products Sales,Zacks
Feb-07-19,"Vertex Pharmaceuticals: New Drug, Same Great Growth Story",Motley Fool
Feb-11-19,Here's Why CRISPR Therapeutics Rose 13.5% in January,Motley Fool
Feb-12-19,"Jim Cramer Gives His Opinion On Cronos, Etsy And More",Benzinga
Feb-14-19,Is Moderna a Buy?,Motley Fool
Feb-19-19,CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement,GlobeNewswire
Feb-21-19,CRISPR Therapeutics Proposes New Members to the Board of Directors,GlobeNewswire
Feb-25-19,"Why Danaher, CRISPR Therapeutics, and Clementia Pharmaceuticals Jumped Today",Motley Fool
Feb-25-19,Biotech Stocks Pop After This Company Used CRISPR Drug In A Patient,Investor's Business Daily
Feb-25-19,Here's Why Gene Therapy Stocks Are Soaring Today,Motley Fool
Feb-26-19,Biotech ETFs Jump on Roche-Spark Deal,Zacks
Feb-26-19,CRISPR Therapeutics Up as Dosing Starts in Thalassemia Study,Zacks
Feb-26-19,Deal on the Way Now that Deadline is Delayed?,Zacks
Feb-27-19,CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2019 Annual Meeting,GlobeNewswire
Feb-27-19,CRISPR Therapeutics Rallies as Gene Stocks Get Hot Again,InvestorPlace
Mar-04-19,Why NOW Is the Time to Buy Gene Therapy Stocks,InvestorPlace
Mar-04-19,S&P Reclaims 2800; NASDAQs Streak Hits 10 Weeks,Zacks
Mar-06-19,CRISPR Therapeutics to Participate in Upcoming Investor Conferences,GlobeNewswire
Mar-07-19,5 Top Gene-Editing Stocks for 2019,Motley Fool
Mar-07-19,Has CRISPR Therapeutics AG (NASDAQ:CRSP) Got Enough Cash?,Simply Wall St.
Mar-21-19,"Should You Buy Bio-Path Stock After 5-Fold Gain? 3 Pros, 3 Cons",InvestorPlace
Mar-21-19,CRISPR and Vertex- Front-Runners in Gene-Therapy,MoneyShow
Mar-26-19,3 Top Small-Cap Stocks to Buy Right Now,Motley Fool
